For research teamsHelp me find a study
Back to all studies
RecruitingEUCTR 2019-001834-33

Efficacy and safety of Sodium Oxybate in reducing alcohol consumption and maintaining abstinence in alcohol-dependent subjects with high and very high drinking risk level. “OXYLIFE Study“

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.

Addiction, Alcohol addictionDrug
In plain English

Key information made simple

What the source confirms

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.

What should you check before joining?

Check the official protocol for eligibility, treatment, visits and assessments. If recruitment is listed, confirm with the team that a specific centre is still accepting participants before taking any next step.

Your next step

Check the study details

Check the official source, then confirm these points with the research team.

View the historical EU CTR record (opens in a new tab)

  • Recruitment and eligibility

    Is a site open, and who can take part?

  • Visits and time

    Where are visits, can any be remote, and how much time is needed?

  • Costs and support

    What costs, reimbursement or compensation apply?

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateNot clearly listed
Recruitment status
Recruiting
Enrollment listed in the registry
240
Sponsor
LABORATORIO FARMACEUTICO CT SRL
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
France, Italy, Poland
Age range
Not clearly listed
Official registry ID
EUCTR 2019-001834-33
Official title
Efficacy and safety of Sodium Oxybate in reducing alcohol consumption and maintaining abstinence in alcohol-dependent subjects with high and very high drinking risk level. “OXYLIFE Study“

Want help reviewing this study?

Loading the security check...
Study ID: EUCTR 2019-001834-33. We help you review the study, but cannot decide medical eligibility.

Check recruitment and locations

EU CTR and CTIS records checked by HopeStage on . Registry information can change. Always confirm availability with the research team.

This study transferred to CTIS. HopeStage uses that newer record for the displayed status. A country's status does not guarantee that an individual site accepts participants.

View the historical EU CTR record (opens in a new tab)View the current CTIS record (opens in a new tab)
Current CTIS country statuses
Historical EU CTR country statuses
  • Italy : Trial now transitioned

The overall study status can differ from each site's status. Open a country to see its locations and their registry status.

France · 6 sites
  • Centre Hospitalier Regional Et Universitaire De Brest — Addictology
    Brest Cedex 2
    Site status: Not listed — confirm with the team
  • Centre Hospitalier Le Vinatier — psychiatry
    Bron Cedex
    Site status: Not listed — confirm with the team
  • Centre Hospitalier Camille Claudel La Couronne — addictology
    La Couronne
    Site status: Not listed — confirm with the team
  • Centre Hospitalier Universitaire De Montpellier — Addictology physician
    Montpellier Cedex 5
    Site status: Not listed — confirm with the team
  • Centre Hospitalier Universitaire De Nimes — Addictology
    Nimes
    Site status: Not listed — confirm with the team
  • Centre Hospitalier Universitaire De Nimes — addictology
    Nimes Cedex 9
    Site status: Not listed — confirm with the team
Italy · 13 sites
  • Azienda Ospedaliera Papa Giovanni XXIII — Department of Addiction
    Bergamo
    Site status: Not listed — confirm with the team
  • Azienda Ospedaliero-Universitaria Di Bologna IRCCS Istituto Di Ricerca E Di Cura A Carattere Scientifico — Medical and Surgical Sciences
    Bologna
    Site status: Not listed — confirm with the team
  • Careggi University Hospital — Department of Preclinical and Clinical Pharmacology
    Florence
    Site status: Not listed — confirm with the team
  • Azienda Sanitaria Locale Napoli 2 Nord — Pathological addictions
    Frattamaggiore
    Site status: Not listed — confirm with the team
  • Azienda Sanitaria Locale Napoli 1 Centro — Department of Addictions
    Naples
    Site status: Not listed — confirm with the team
  • Azienda Sanitaria Locale Napoli 1 Centro — Department of Pathological Addictions
    Naples
    Site status: Not listed — confirm with the team
  • Azienda Sanitaria Locale Della Provincia Di Biella — Addictions
    Ponderano
    Site status: Not listed — confirm with the team
  • Azienda Sanitaria Locale Della Provincia Di Biella — Pathology of Addiction
    Ponderano
    Site status: Not listed — confirm with the team
  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS — Internal Medicine
    Rome
    Site status: Not listed — confirm with the team
  • Azienda Sanitaria Provinciale di Siracusa — Addictions
    Siracusa
    Site status: Not listed — confirm with the team
  • Azienda Sanitaria Locale di Napoli 3 Sud — Addictions
    Torre del Greco (NA)
    Site status: Not listed — confirm with the team
  • Azienda Socio Sanitaria Territoriale Di Bergamo Ovest — Department of Mental Health and Addictions
    Treviglio
    Site status: Not listed — confirm with the team
  • Azienda Sanitaria Locale Citta Di Torino — Integrated Department of Addictions
    Turin
    Site status: Not listed — confirm with the team
Poland · 6 sites
  • Centrum Medyczne Intercor Sp. z o.o. — psychiatry
    Bydgoszcz
    Site status: Not listed — confirm with the team
  • M2M Med. Sp. z o.o. Sp. j. — psychiatry
    Katowice
    Site status: Not listed — confirm with the team
  • Specjalistyczny Psychiatryczny Zespol Opieki Zdrowotnej W Lodzi — psychiatry
    Lodz
    Site status: Not listed — confirm with the team
  • M2M Med. Sp. z o.o. Sp. j. — psychiatry
    Rybnik
    Site status: Not listed — confirm with the team
  • Inventiva Biomedical And Research Sp. z o.o. — psychiatry
    Tuszyn
    Site status: Not listed — confirm with the team
  • Clinhouse Sp. z o.o. — psychiatry
    Zabrze
    Site status: Not listed — confirm with the team
In practice

For you

Participation may contribute to research. Personal benefit is not guaranteed.

Ask the research team to explain the activities, time commitment, and follow-up involved.

Study sites are listed. Confirm the relevant site and any travel before making plans.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What does the official source confirm?

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.

Is this study recruiting?

The public registry lists this study as recruiting. Individual sites may have different statuses. The research team must confirm whether a site is open and whether you meet the criteria.

How can I check the participation requirements?

Check the official protocol for the criteria, treatment and planned assessments. The research team must confirm visits, risks, open centres and your eligibility.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me
Related studies

Explore related studies

Other studies that may be relevant based on condition, country, or study type.